Gene Vector Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 6

Gene Vector General Information

Description

Developer of novel adeno-associate virus (AAV) gene therapy drugs designed for the medical field. The company focuses on gene therapy for major diseases such as hereditary diseases, cardiovascular and cerebrovascular diseases, and neurodegenerative diseases, enabling a complete AAV new drug research and development technology chain to deliver novel biotherapy solutions.

Contact Information

Website
www.jwksw.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Sanyi Innovation Center
  • No. 18, North Section of Bayi Road, Wenjiang District
  • Chengdu, Sichuan 611135
  • China
+86 028
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Sanyi Innovation Center
  • No. 18, North Section of Bayi Road, Wenjiang District
  • Chengdu, Sichuan 611135
  • China
+86 028

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gene Vector Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 31-Jan-2024 Completed Clinical Trials - General
3. Later Stage VC 17-May-2023 Completed Clinical Trials - General
2. Early Stage VC 08-Nov-2022 Completed Clinical Trials - General
1. Early Stage VC 25-Jan-2022 Completed Clinical Trials - General
To view Gene Vector’s complete valuation and funding history, request access »

Gene Vector Executive Team (2)

Name Title Board Seat
Yang Yang Ph.D Co-Founder & General Manager
Yuquan Wei Ph.D Co-Founder & Chairman
To view Gene Vector’s complete executive team members history, request access »

Gene Vector Board Members (1)

Name Representing Role Since
Yuquan Wei Ph.D Self Co-Founder & Chairman
To view Gene Vector’s complete board members history, request access »

Gene Vector Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guanghua Kaiyuan Capital Asset Manager Minority
Neowing Capital Venture Capital Minority
Wuhan Institute of Biotechnology Government Minority
Ming Capital Venture Capital Minority
Wuhan East Lake High Technology Group Company Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Gene Vector FAQs

  • When was Gene Vector founded?

    Gene Vector was founded in 2017.

  • Who is the founder of Gene Vector?

    Yang Yang Ph.D and Yuquan Wei Ph.D are the founders of Gene Vector.

  • Where is Gene Vector headquartered?

    Gene Vector is headquartered in Chengdu, China.

  • What industry is Gene Vector in?

    Gene Vector’s primary industry is Drug Discovery.

  • Is Gene Vector a private or public company?

    Gene Vector is a Private company.

  • What is Gene Vector’s current revenue?

    The current revenue for Gene Vector is .

  • Who are Gene Vector’s investors?

    Guanghua Kaiyuan Capital, Neowing Capital, Wuhan Institute of Biotechnology, Ming Capital, and Wuhan East Lake High Technology Group Company are 5 of 6 investors who have invested in Gene Vector.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »